Guava Technologies, CHAI, NIH, Millipore, Serologicals | GenomeWeb

Clinton Foundation Pens Agreement with Guava for Discounted CD4 Testing Tech

Guava Technologies said this week that the Clinton Foundation HIV/AIDS Initiative (CHAI) has signed an agreement with Guava designed to reduce the cost of CD4 testing for HIV patient monitoring by up to 50 percent.

Under the terms of the agreement, Guava will supply its Easy CD4 System at a discounted price to the members of CHAI's Procurement Consortium, a coalition of 56 developing countries around the world including 27 African nations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.